Login / Signup
The Inhibitors of Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) as Potential Enhancers of Cancer Immunotherapy and Type 1 (PTPN1) as Treatment of Metabolic Diseases.
Ahmed F Abdel-Magid
Published in:
ACS medicinal chemistry letters (2021)
Keyphrases
</>
protein protein
small molecule
risk assessment
climate change